ORKA Q1 2024 Earnings — Oruka Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ORKAOruka Therapeutics, Inc.

$1B

Q1 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$19,000

Operating Income

-$2M

Net Income

-$2M

EPS (Diluted)

$-0.24

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$168,000

Free Cash Flow

-$168,000

Stock-Based Comp.

$85,000

Balance Sheet

Total Assets

$37M

Total Liabilities

$2M

Stockholders' Equity

$35M

Cash & Equivalents

$36M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$19,000	-$29,000	+34.5%
Operating Income	-$2M	-$2M	-38.2%
Net Income	-$2M	-$1M	-49.3%